Search Forum
Blog Entry# 4839952
Posted: Jan 10 2021 (10:32)
5 Responses
Last Response: Jan 10 2021 (11:48)
5 Responses
Last Response: Jan 10 2021 (11:48)
Jan 10 2021 (10:32) COVID-19 vaccination drive in India to begin on Jan 16; PM Narendra Modi reviews preparedness
Harsh12345ER~ 360 news posts
Harsh12345ER~ 360 news posts
India will begin its COVID-19 vaccination drive on January 16, close on heels of other global countries.
...
...
Covishield (AstraZeneca-Oxford) vaccine has an efficacy rate of around 70% which isn't impressive at all. Indian government should opt for Moderna or pfizer vaccine having 95% efficacy. Even the much ridiculed Sputnik has an efficacy rate of 90% then why government is going with Covishield is beyond my understanding. If you can invest 1000 crores on new Parliament building then why compromise with the vaccine just bcoz of price issues.
Moderna is not manufactured in India
We have to import it from US
Also Moderna /Pfizer require -70•C cold storage which is not available in India
Also Sputnik is currently under Trials in India
We have to import it from US
Also Moderna /Pfizer require -70•C cold storage which is not available in India
Also Sputnik is currently under Trials in India
We don't have required infrastructure to handle these mRNA based vaccines. Their storage is done at -70°C, and our cold storage chain isn't optimized for such temperatures. Moreover Sputnik V vaccine is under Phase 3 trials, and it'll be approved soon.
Main reason for opting Oxford vaccine is it's cheap cost and easy transportation at 2-8°C. Even Sputnik V needs to be stored at -20°C, although it is cheap.
Main reason for opting Oxford vaccine is it's cheap cost and easy transportation at 2-8°C. Even Sputnik V needs to be stored at -20°C, although it is cheap.